ASTRAZENECA PLC DL-,25/ GB0009895292 /
5/2/2024 6:00:45 PM | Chg. -0.350 | Volume | Bid6:40:26 PM | Ask6:40:26 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
141.450EUR | -0.25% | 1,956 Turnover: 279,487.450 |
141.250Bid Size: 60 | 141.600Ask Size: 60 | 219.11 bill.EUR | - | - |
GlobeNewswire
1:00 PM
CytoSorbents May 6, 2024 Virtual KOL and Analyst-Investor Day: STAR-T Pivotal Trial Topline Results ...
GlobeNewswire
7:00 AM
Press Release: Beyfortus real-world evidence published in The Lancet shows 82% reduction in infant R...
GlobeNewswire
3/28
HUTCHMED Announces Savolitinib sNDA Accepted in China for Treatment-Naïve or Previously Treated Pati...
GlobeNewswire
2/26
FibroGen Regains All Rights to Roxadustat from AstraZeneca in the United States and Other AstraZenec...
GlobeNewswire
2/5
Yiviva Announces Memorandum of Understanding with AstraZeneca to Develop Platforms, Technologies, an...